Concepedia

Shailaja Kunda

SK

Statistics

Publications

1

Citations

21

H-Index

1

Active since

1989

Affiliations

Integrated BioTherapeutics (United States)(Current)

Shailaja Kunda is an author at Integrated BioTherapeutics (United States) specializing in therapeutic monoclonal antibodies, exposure time dependence, and conjugation chemistry for antibodies.

Publications per year

1989–1989

1

Publications

1

Immunoconjugates of doxorubicin and murine antihuman breast carcinoma monoclonal antibodies prepared via an N-hydroxysuccinimide active ester intermediate of cis-aconityl-doxorubicin: preparation and in vitro cytotoxicity.

John R. Ogden, Kam Leung, Shailaja Kunda et al. · PubMed · 1989 · 21 citations

, , +17

1–1 of 1